Malaria Consortium – Seasonal Malaria Chemoprevention

Abstract

Malaria Consortium’s seasonal malaria chemoprevention (SMC) program is one of GiveWell’s top charities. The main factor driving our grantmaking to Malaria Consortium is an analysis of its program’s cost-effectiveness. We summarize our cost-effectiveness analysis in detail in a separate report. This page provides additional information on Malaria Consortium’s program, our qualitative assessment of Malaria Consortium, and the monitoring and evaluation data it shares. This information feeds into our overall recommendation for Malaria Consortium (alongside cost-effectiveness) and provides additional context so that we can understand and appropriately model the impact of its SMC program.